共 50 条
- [11] Cardiac disease-free survival in patients with Thalassemia major treated with subcutaneous deferoxamine. An update of the Toronto Cohort 1600, Publ by New York Acad of Sciences, New York, NY, USA (612):
- [18] Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea FINLAY, 2021, 11 (01): : 66 - 73
- [20] PROLONGED SURVIVAL IN PATIENTS WITH BETA-THALASSEMIA MAJOR TREATED WITH DEFEROXAMINE JOURNAL OF PEDIATRICS, 1991, 118 (04): : 540 - 545